Advanced quality assessment of Sanshishi ( Gardenia jasminoides Ellis) and Kampo medicines using a monoclonal antibody against geniposide
Kanta Noguchi,Daisuke Imahori,Riko Nishiura,Poomraphie Nuntawong,Waraporn Putalun,Hiroyuki Tanaka,Satoshi Morimoto,Seiichi Sakamoto
DOI: https://doi.org/10.1016/j.fitote.2024.105829
IF: 3.204
2024-01-26
Fitoterapia
Abstract:Gardenia jasminoides Ellis, a plant widely used in traditional medicine, is known for its array of biological activities. A key bioactive compound, geniposide (GE), an iridoid glycoside, significantly contributes to the medicinal properties of the plant, with potential side effects. Thus, a reliable and efficient method for GE detection is required to ensure the quality of medicinal-grade G. jasminoides Ellis. This study developed such a method by first synthesizing GE–bovine serum albumin conjugates to function as immunizing agents in mice. This led to the production of a monoclonal antibody (mAb 3A6) against GE from the fusion of splenocytes from immunized mice with myeloma cells (P3U1), resulting in a hybridoma that produces mAb 3A6. Thereafter, we developed a mAb 3A6-based indirect competitive enzyme-linked immunosorbent assay (icELISA). The icELISA exhibited satisfactory sensitivity (0.391–12.5 μg/ml) and repeatability (coefficients of variation <10%). The accuracy of this method was validated through a spike-recovery assay (recovery of 101–112%). Furthermore, the icELISA was employed to determine the GE content in plant and Kampo medicine samples. The GE content positively correlated with those determined by high-performance liquid chromatography-ultraviolet. The proposed icELISA is rapid, cost-effective, and reliable for high-throughput GE detection in G. jasminoides Ellis, thereby contributing to the improved quality control and standardization of this valuable medicinal plant.
pharmacology & pharmacy,chemistry, medicinal